Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: A meta-analysis of randomized controlled trials

JAMA

Volumn 292, Issue 23, 2004, Pages 2874-2879

  Desai, Akshay S ^a,b   Fang, James C ^a   Maisel, William H ^a   Baughman, Kenneth L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; METOPROLOL; PLACEBO; PROPAFENONE;

CARDIOMYOPATHY; CAUSE OF DEATH; CLINICAL TRIAL; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; DEFIBRILLATOR; FOLLOW UP; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; IMPLANTATION; META ANALYSIS; MORTALITY; PATIENT SELECTION; PRIMARY PREVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK REDUCTION; SECONDARY PREVENTION; SUDDEN DEATH; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

EID: 10344249396     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.292.23.2874     Document Type: Review

References (26)

1. The Antiarrhythmic versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhthmias. N Engl J Med. 1997;337:1576-1583.
2. Connolly SJ, Gent M, Roberts RS, et al. Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation. 2000;101:1297-1302.
3. Kuck KH, Cappato R, Siebels J, Ruppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation. 2000;102:748-754.
4. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implantable defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med. 1996;335:1933-1940.
5. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-883.
6. Buxton AE, Lee KL, Fisher JD, et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med. 1999;341:1882-1890.
7. Connolly SJ, Hallstrom AP, Cappato R, et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials: AVID, CASH, and CIDS. Eur Heart J. 2000;21:2071-2078.
8. Hsia HH, Callans DJ, Marchlinski FE. Characterization of endocardial electrophysiologic substrate in patients with nonischemic cardiomyopathy and monomorphic ventricular tachycardia. Circulation. 2003;108: 704-710.
9. Grimm W, Hoffmann J, Menz V, et al. Programmed ventricular stimulation for arrhythmia risk prediction in patients with idiopathic dilated cardiomyopathy and nonsustained ventricular tachycardia. J Am Coll Cardiol. 1998;32:739-745.
10. Grimm W, Christ M, Bach J. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study. Circulation. 2003;108:2883-2891.
11. Tamburro P, Wilber D. Sudden death in idiopathic dilated cardiomyopathy. Am Heart J. 1992;124: 1035-1045.
12. Fonarow GC, Feliciano Z, Boyle NG, et al. Improved survival in patients with nonischemic advanced heart failure and syncope treated with an implantable cardioverter-defibrillator. Am J Cardiol. 2000; 85:981-985.
13. Russo AM, Verdino R, Schorr C, et al. Occurrence of implantable defibrillator events in patients with syncope and nonischemic dilated cardiomyopathy Am J Cardiol. 2001;88:1444-1446.
14. Bardy G. SCD-HeFT: the Sudden Cardiac Death in Heart Failure Trial. Presented as a late-breaking clinical trial at the American College of Cardiology Scientific Sessions, March 8, 2004. Available at: http://www.sicr.org /scdheft_results_acc_lbcc.pdf. Accessed May 15, 2004.
15. Kadish A, Dyer A, Daubert J, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004;350: 2151-2158.
16. Bansch D, Antz M, Boczor S, et al. Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy. Circulation. 2002;105:1453-1458.
17. Strickberger SA, Hummel JD, Bartlett TG, et al. Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic non-sustained ventricular tachycardia (AMIOVIRT). J Am Coll Cardiol. 2003;41:1707-1712.
18. Haynes RB, Wilczynski N, McKibbon KA, et al. Developing optimal search strategies for conducting clinically sound studies in MEDLINE. J Am Med Inform Assoc. 1994;1:447-458.
19. Moher D, Cook DJ, Eastwood S, et al. Improving the quality of reports of meta-analyses of randomized controlled trials: the QUOROM statement. Lancet. 1999;354:1896-1900.
20. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088-1099.
21. Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140-2150.
22. Knight BP, Goyal R, Pelosi F, et al. Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator. J Am Coll Cardiol. 1999;33:1964-1970.
23. Steinberg JS, Beckman K, Greene HL, et al. Follow-up of patients with unexplained syncope and inducible ventricular tachyarrhythmias. J Cardiovasc Electrophysiol. 2001;12:996-1001.
24. Rankovic V, Karha J, Passman R, et al. Predictors of appropriate implantable cardioverter-defibrillator therapy in patients with dilated cardiomyopathy. Am J Cardiol. 2002;89:1072-1076.
25. Grimm W, Hoffman J, Muller H-H, et al. Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holler, and a left ventricular ejection fraction below 30%. J Am Coll Cardiol. 2002;39:780-787.
26. Levine JH, Waller T, Hoch D, et al. Implantable cardioverter defibrillator: use in patients with no symptoms and at high risk. Am Heart J. 1996;131:59-65.